Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory to Standard Therapies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05037149
What this trial is testing

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

Who this might be right for
Solid Tumor
Sirnaomics 50
Not applicableStudy completedNCT05700565
What this trial is testing

Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype

Who this might be right for
Immune-related Adverse Event
Lucie Heinzerling 46
Very early researchLooking for participantsNCT06898437
What this trial is testing

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Radioiodine Refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital 20
Early research (Phase 1)Ended earlyNCT01118819
What this trial is testing

Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

Who this might be right for
Solid Tumor Malignancies
BioMed Valley Discoveries, Inc 5
Testing effectiveness (Phase 2)Study completedNCT05025631
What this trial is testing

A Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment（DOFEMCRC）

Who this might be right for
Colorectal Cancer
Zhen-Yu Ding 29
Not applicableStudy completedNCT02139215
What this trial is testing

Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Metastatic
PeriPharm 72
Early research (Phase 1)Study completedNCT04686383
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors

Who this might be right for
Resistant or Refractory Solid Tumors
Calgent Biotechnology Co., Ltd 17
Early research (Phase 1)Not Yet RecruitingNCT07260162
What this trial is testing

Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)

Who this might be right for
Bladder Cancer
Institut Cancerologie de l'Ouest 24
Early research (Phase 1)Ended earlyNCT00089089
What this trial is testing

Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas

Who this might be right for
Hematopoietic/Lymphoid CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT01837602
What this trial is testing

CMet CAR RNA T Cells Targeting Breast Cancer

Who this might be right for
Metastatic Breast CancerTriple Negative Breast Cancer
University of Pennsylvania 6
Early research (Phase 1)UnknownNCT05068453
What this trial is testing

Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Who this might be right for
Melanoma Stage IV
Peking University Cancer Hospital & Institute 15
Early research (Phase 1)Ended earlyNCT00689065
What this trial is testing

Safety Study of CALAA-01 to Treat Solid Tumor Cancers

Who this might be right for
CancerSolid Tumor
Calando Pharmaceuticals 24
Early research (Phase 1)Study completedNCT00022295
What this trial is testing

Phenoxodiol in Treating Patients With Refractory Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Kazia Therapeutics Limited 36
Early research (Phase 1)Looking for participantsNCT05735184
What this trial is testing

Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaMixed Lineage Leukemia Gene MutationRefractory AML+7 more
Kura Oncology, Inc. 420
Testing effectiveness (Phase 2)Study completedNCT00109707
What this trial is testing

Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic Syndrome+1 more
Novartis Pharmaceuticals 507
Early research (Phase 1)Study completedNCT00741234
What this trial is testing

A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine

Who this might be right for
Solid TumorsHematologic MalignanciesMyelodysplastic Syndrome
S*BIO 85
Testing effectiveness (Phase 2)Study completedNCT00005941
What this trial is testing

Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer

Who this might be right for
Cervical CancerVaginal Cancer
Fred Hutchinson Cancer Center
Early research (Phase 1)UnknownNCT03503604
What this trial is testing

Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Who this might be right for
Solid Tumors
SuZhou Stainwei Biotech Inc. 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175389
What this trial is testing

JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure

Who this might be right for
Refractory Pancreatic Ductal AdenocarcinomaRefractory Pancreatic Adenocarcinoma
West China Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02169115
What this trial is testing

Urticaria Facticia Treatment With Omalizumab (UFO)

Who this might be right for
Symptomatic Dermographism
Charite University, Berlin, Germany 61
Next Page